Literature DB >> 24743001

A computerized global MR image feature analysis scheme to assist diagnosis of breast cancer: a preliminary assessment.

Qian Yang1, Lihua Li2, Juan Zhang3, Guoliang Shao3, Bin Zheng4.   

Abstract

OBJECTIVES: To develop a new computer-aided detection scheme to compute a global kinetic image feature from the dynamic contrast enhanced breast magnetic resonance imaging (DCE-MRI) and test the feasibility of using the computerized results for assisting classification between the DCE-MRI examinations associated with malignant and benign tumors.
MATERIALS AND METHODS: The scheme registers sequential images acquired from each DCE-MRI examination, segments breast areas on all images, searches for a fraction of voxels that have higher contrast enhancement values and computes an average contrast enhancement value of selected voxels. Combination of the maximum contrast enhancement values computed from two post-contrast series in one of two breasts is applied to predict the likelihood of the examination being positive for breast cancer. The scheme performance was evaluated when applying to a retrospectively collected database including 80 malignant and 50 benign cases.
RESULTS: In each of 91% of malignant cases and 66% of benign cases, the average contrast enhancement value computed from the top 0.43% of voxels is higher in the breast depicted suspicious lesions as compared to another negative (lesion-free) breast. In classifying between malignant and benign cases, using the computed image feature achieved an area under a receiver operating characteristic curve of 0.839 with 95% confidence interval of [0.762, 0.898].
CONCLUSIONS: We demonstrated that the global contrast enhancement feature of DCE-MRI can be relatively easily and robustly computed without accurate breast tumor detection and segmentation. This global feature provides supplementary information and a higher discriminatory power in assisting diagnosis of breast cancer.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer image biomarker; Computer-aided diagnosis (CAD); Dynamic contrast enhanced breast magnetic resonance imaging (DCE-MRI)

Mesh:

Substances:

Year:  2014        PMID: 24743001      PMCID: PMC4142051          DOI: 10.1016/j.ejrad.2014.03.014

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  20 in total

Review 1.  MRI of the breast.

Authors:  S C Rankin
Journal:  Br J Radiol       Date:  2000-08       Impact factor: 3.039

2.  Computerized interpretation of breast MRI: investigation of enhancement-variance dynamics.

Authors:  Weijie Chen; Maryellen L Giger; Li Lan; Ulrich Bick
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

3.  Breast MRI lesion classification: improved performance of human readers with a backpropagation neural network computer-aided diagnosis (CAD) system.

Authors:  Lina Arbash Meinel; Alan H Stolpen; Kevin S Berbaum; Laurie L Fajardo; Joseph M Reinhardt
Journal:  J Magn Reson Imaging       Date:  2007-01       Impact factor: 4.813

4.  Improved lesion detection in MR mammography: three-dimensional segmentation, moving voxel sampling, and normalized maximum intensity-time ratio entropy.

Authors:  Gökhan Ertaş; H Ozcan Gülçür; Mehtap Tunaci
Journal:  Acad Radiol       Date:  2007-02       Impact factor: 3.173

5.  Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.

Authors:  Teresa C Williams; Wendy B DeMartini; Savannah C Partridge; Sue Peacock; Constance D Lehman
Journal:  Radiology       Date:  2007-05-16       Impact factor: 11.105

6.  MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.

Authors:  Christiane K Kuhl; Simone Schrading; Heribert B Bieling; Eva Wardelmann; Claudia C Leutner; Roy Koenig; Walther Kuhn; Hans H Schild
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321

7.  Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images.

Authors:  Weijie Chen; Maryellen L Giger; Hui Li; Ulrich Bick; Gillian M Newstead
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

8.  The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumors.

Authors:  Anda Preda; Karl Turetschek; Heike Daldrup; Eugenia Floyd; Viktor Novikov; David M Shames; Timothy P L Roberts; Wayne O Carter; Robert C Brasch
Journal:  Invest Radiol       Date:  2005-06       Impact factor: 6.016

9.  Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.

Authors:  Francesco Sardanelli; Alfonso Fausto; Anastassia Esseridou; Giovanni Di Leo; Miles A Kirchin
Journal:  Invest Radiol       Date:  2008-04       Impact factor: 6.016

10.  Long-term psychosocial consequences of false-positive screening mammography.

Authors:  John Brodersen; Volkert Dirk Siersma
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

View more
  11 in total

1.  Computer-Aided Diagnosis Scheme for Distinguishing Between Benign and Malignant Masses in Breast DCE-MRI.

Authors:  Emi Honda; Ryohei Nakayama; Hitoshi Koyama; Akiyoshi Yamashita
Journal:  J Digit Imaging       Date:  2016-06       Impact factor: 4.056

2.  A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations.

Authors:  Qian Yang; Lihua Li; Juan Zhang; Guoliang Shao; Bin Zheng
Journal:  Med Phys       Date:  2015-01       Impact factor: 4.071

3.  Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.

Authors:  Faranak Aghaei; Maxine Tan; Alan B Hollingsworth; Bin Zheng
Journal:  J Magn Reson Imaging       Date:  2016-04-15       Impact factor: 4.813

Review 4.  MRI Radiogenomics in Precision Oncology: New Diagnosis and Treatment Method.

Authors:  Xiao-Xia Yin; Mingyong Gao; Wei Wang; Yanchun Zhang
Journal:  Comput Intell Neurosci       Date:  2022-07-07

5.  MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.

Authors:  Hui Li; Yitan Zhu; Elizabeth S Burnside; Karen Drukker; Katherine A Hoadley; Cheng Fan; Suzanne D Conzen; Gary J Whitman; Elizabeth J Sutton; Jose M Net; Marie Ganott; Erich Huang; Elizabeth A Morris; Charles M Perou; Yuan Ji; Maryellen L Giger
Journal:  Radiology       Date:  2016-05-05       Impact factor: 11.105

6.  Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapy.

Authors:  Faranak Aghaei; Maxine Tan; Alan B Hollingsworth; Wei Qian; Hong Liu; Bin Zheng
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

7.  Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI.

Authors:  Jiandong Yin; Jiawen Yang; Lu Han; Qiyong Guo; Wei Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-03-04

8.  Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set.

Authors:  Hui Li; Yitan Zhu; Elizabeth S Burnside; Erich Huang; Karen Drukker; Katherine A Hoadley; Cheng Fan; Suzanne D Conzen; Margarita Zuley; Jose M Net; Elizabeth Sutton; Gary J Whitman; Elizabeth Morris; Charles M Perou; Yuan Ji; Maryellen L Giger
Journal:  NPJ Breast Cancer       Date:  2016-05-11

9.  Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.

Authors:  Ming Fan; Hui Li; Shijian Wang; Bin Zheng; Juan Zhang; Lihua Li
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

10.  Discrimination between malignant and benign mass-like lesions from breast dynamic contrast enhanced MRI: semi-automatic vs. manual analysis of the signal time-intensity curves.

Authors:  Jiandong Yin; Jiawen Yang; Zejun Jiang
Journal:  J Cancer       Date:  2018-02-12       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.